EMHTF

Trading Strategies

How One Quick Cell Phone Pic Captured $2.9 Billion in CBD Profit Power

I made a big call at the very end of 2018.

I did it because the results I was seeing in my proprietary "NICIlytics" cannabis stock analysis were crystal clear: A monster investing trend was beginning to get underway…

So I felt perfectly comfortable predicting "2019 will be the Year of CBD."

In January, CBD was a small niche, a little-known supplement sold only through websites, a handful of health- and wellness-oriented stores, and special pilot programs.

Barely five months into the year, and we're seeing CBD-infused products sold nationwide.

Online, of course, but also in shoe stores, malls, and major drug store chains.

Although the CBD boom is still in its very early stages, I still manage to be (pleasantly) surprised by how widely it's spread in such a short time.

In one case, it literally snuck up on me – though I was happy to see it.

Let me show you a quick picture I snapped at the grocery store the other day. In just this one cell phone snap, I captured some potent CBD stocks...

Trading Strategies

The Shocking Ways "Big Government" Is Sending Cannabis Stocks Soaring

Summer 2018 was a season of surprises – mostly great ones – for cannabis investing.

Not long ago, few foresaw Corona's parent corporation Constellation Brands investing $3.8 million in what was already the world's biggest cannabis producer in its second deal together in less than a year…

Or Coca-Cola Co. starting negotiations with a cannabis company about a potential CBD-based beverage…

Or a British pharmaceutical developer getting the first U.S. Food & Drug Association approval for a cannabis-based medicine. 

Yet every one of those events happened… in short order.

With each time, cannabis stocks soared accordingly, especially for the companies directly involved.

Big news means major moves when it comes to cannabis investing.

But what I see as the biggest, most shocking developments of late haven't been happening in a board room. They've been happening in the shadows of the Capitol in Washington, D.C.

The U.S. cannabis policy thaw is already underway, and the ongoing developments associated with it are going to be game changers for investors who don't wait for too long on the sidelines.

These are first-time events that herald a brand-new era of cannabis profits for shareholders.

We're talking about real movement in the slow and steady end of the longtime federal prohibition of marijuana.

Here are the three things I'm watching closest...